The Journal of clinical endocrinology and metabolism
The most recent articles from:
March 2014
-
J. Clin. Endocrinol. Metab. · Mar 2014
Randomized Controlled Trial Multicenter Study Comparative StudyPasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Biochemical control reduces morbidity and increases life expectancy in patients with acromegaly. With current medical therapies, including the gold standard octreotide long-acting-release (LAR), many patients do not achieve biochemical control. ⋯ Pasireotide LAR demonstrated superior efficacy over octreotide LAR and is a viable new treatment option for acromegaly.